Hong Kong-listed company Linghang Pharmaceutical Biotech rose more than 10% during the session

This article is machine translated
Show original

On July 15, according to market data, the Hong Kong-listed company Leading Medical Biotechnology (HK0399) rose by over 10% during trading, with a current trading volume of 8 million Hong Kong dollars.

Leading Medical Biotechnology previously announced plans to acquire the full equity of blockchain project Conflux to expand its layout in the blockchain field, with two founding members of Conflux currently serving as its executive directors.

Source
Disclaimer: The content above is only the author's opinion which does not represent any position of Followin, and is not intended as, and shall not be understood or construed as, investment advice from Followin.
Like
Add to Favorites
Comments